ZEOX — Zeo Scientifix Income Statement
0.000.00%
Last trade - 00:00
- $14.45m
- $14.39m
- $4.56m
- 52
- 21
- 74
- 47
2019 October 31st | 2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.7 | 3.06 | 5.6 | 6.49 | 4.56 |
Cost of Revenue | |||||
Gross Profit | 1.4 | 2.66 | 5.05 | 5.74 | 4.05 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3.48 | 15.5 | 18.3 | 15.2 | 11.4 |
Operating Profit | -1.78 | -12.4 | -12.7 | -8.72 | -6.87 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -1.74 | -12.6 | -12.8 | -8.9 | -6.99 |
Provision for Income Taxes | |||||
Net Income After Taxes | -1.74 | -12.6 | -12.8 | -8.9 | -6.99 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -1.74 | -12.6 | -12.8 | -8.9 | -6.99 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -1.74 | -12.6 | -12.8 | -8.9 | -6.99 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.744 | -3.75 | -2.41 | -1.59 | -1.03 |